Aurora kinase inhibitor VX-680, Purity ≥98%

Cat. No.: X23-10-ZQ489

Aurora kinase inhibitor VX-680, Purity ≥98%

Synonym: Tozasertib; 639089-54-6; VX-680; MK-0457; VX 680; MK 0457; VX680; Aurora kinase inhibitor

  • MDL: MFCD13185152
  • CAS Number: 639089-54-6
  • Compound CID: 5494449
Product Size
25 mg; 50 mg; 100 mg; 250 mg
Price
Datasheet
MSDS
Properties
Description
VX-680, soluble in DMSO and insoluble in ethanol and water, is an Aurora kinase inhibitor that disrupts cell division processes. It targets Aurora A, Aurora B, Aurora C, Bcr-Abl, and FLT3.
Molecular Weight
464.6
Molecular Formula
C23H28N8OS
Targets
Aurora A: 0.6 nM (Ki app); Aurora B: 18 nM (Ki app); Aurora C: 4.6 nM (Ki app); Bcr-Abl: 30 nM (Ki); FLT3: 30 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Solubility
DMSO: 90 mg/mL (193.71 mM); Water: Insoluble; Ethanol: Insoluble
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
VX-680, also known as MK-0457, is used to study the inhibition of Aurora kinases in cancer therapy.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.